Stewart, Ross

Development of PARP and immune-checkpoint inhibitor combinations

Stewart, R. A., Pilié, P. G., & Yap, T. A. (2018) · Cancer Research

PARP inhibition in cancer therapyCancer Immunotherapy and Biomarkers

Cited by 239

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Skoulidis, F., Araujo, H. A., Do, M. T., Qian, Y., Sun, X., Galan-Cobo, A., Le, J. T., Montesion, M., Palmer, R., Jahchan, N., et al. (2024) · Nature

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 194

Pretrained transformers applied to clinical studies improve predictions of treatment efficacy and associated biomarkers

Arango-Argoty, G., Kipkogei, E., Stewart, R., Patra, A., Kagiampakis, I., & Jacob, E. (2023) · Nature Communications

Machine Learning in HealthcareRadiomics and Machine Learning in Medical Imaging

Cited by 34